ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

HYL Hyloris Pharmaceuticals SA

11.70
-0.15 (-1.27%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Hyloris Pharmaceuticals SA HYL Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-0.15 -1.27% 11.70 11:40:00
Open Price Low Price High Price Close Price Prev Close
11.90 11.70 11.90 11.70 11.85
more quote information »

Recent News

Date Time Source Heading
3/14/202402:00GLOBEHyloris Reports Full Year Results for 2023 & Provides..
3/14/202401:59GLOBECommuniqué à la requête de la FSMA sur les transactions avec..
3/08/202401:00GLOBEHyloris to Report 2023 Full-Year Results on 14 March 2024
2/27/202412:00GLOBEHyloris Announces Launch of Maxigesic® IV in the U.S. and..
2/14/202412:00GLOBEHyloris Recrute un Premier Patient dans le Cadre d'un Essai..
1/30/202401:00GLOBEHyloris et Purna Female Healthcare Annoncent des Résultats..
1/18/202413:00GLOBEHyloris Elargit son Portefeuille de Produits avec un Nouveau..
1/16/202413:30GLOBELa FDA Américaine Accorde la Qualification de Médicament..
1/16/202411:30GLOBEPleco Therapeutics receives FDA Orphan Drug Designation
12/26/202312:00GLOBEHyloris Annonce des Résultats Cliniques Positifs pour son..
12/21/202312:30GLOBEHyloris élargit son Portefeuille avec un Nouveau Produit..
12/04/202301:00GLOBEHyloris annonce l'approbation du Gel Podofilox par la FDA..
10/24/202301:00GLOBEHyloris annonce un accord de licence pour l'Atomoxetine Oral..
9/06/202316:00GLOBEHyloris Pharmaceuticals Reports 2023 Half-Year Results and..
6/22/202301:00GLOBEHyloris annonce le recrutement d’un premier patient pour son..
6/13/202311:59GLOBEHyloris shareholders approve all resolutions at the Annual..
6/08/202311:59GLOBEHyloris Pharmaceuticals perçoit 1 million € de financement..
5/02/202301:00GLOBEHyloris announces potential registration date for Maxigesic®..
4/28/202301:00GLOBEHyloris publie son rapport annuel 2022 et ses objectifs ESG

Your Recent History

Delayed Upgrade Clock